Over the past 12 months, the stock price was flat, and as of Friday, shares were trading 16.35% below the 52-week high and 118.38% above the 52-week low.
The American financial institution has a market cap of $220.67 billion and an enterprise value of $228.32 billion.
The biotechnology company has a market cap of $2.02 billion, an enterprise value of $1.92 billion and insider ownership of 7.4%.